Loading...
Thumbnail Image
Publication

Antibiotic Resistance Caused by Class A β-Lactamases

Journal Title
Readers/Advisors
Middleton, Elizabeth
Journal Title
Term and Year
Spring 2021
Publication Date
2021
Book Title
Publication Volume
Publication Issue
Publication Begin
Publication End
Number of pages
Research Projects
Organizational Units
Journal Issue
Abstract
The most effective and most used antibiotics for treating infections are known as beta-lactams. Unfortunately, more and more bacteria are developing different ways to fight against these antibiotics. The most common causes of resistance involve the creation of β-lactamase, which allows hydrolysis of the β-lactam ring, which results in the inactivation of the drug. A way around this is using β-lactamase inhibitors like clavulanic acid, sulbactam and tazobactam in combination with β-lactams for treatment. But, there is still bacterial resistance that occurs with combination therapy and it keeps evolving, which results in people developing immunity to these medications. As a result, scientists are looking to find broad-spectrum β-lactamase inhibitors that successfully fight β-lactamases. (Eiamphungporn et al., 2018)
Citation
DOI
Description
Accessibility Statement
Purchase College - State University of New York (PC) is committed to ensuring that people with disabilities have an opportunity equal to that of their nondisabled peers to participate in the College's programs, benefits, and services, including those delivered through electronic and information technology. If you encounter an access barrier with a specific item and have a remediation request, please contact lib.ir@purchase.edu.
Embedded videos